[PubMed: 6095132] 497
I think with all these new modalities, this happened with dry needling and then BFR too had its thing, is it starts to get really popular and you hear a lot of buds around the mechanismic studies, but at the end of the day, the first thing that we have to take care of is safety
STAT (February 2026) describes the gap between community claims and human data as "staggering." TB-500 preclinical data: muscle, heart, cornea, skin The TB-500 data is less voluminous than that of BPC-157 but more diversified in research teams
Metab Syndr Relat Disord
Theyre choosing the right chemical, the right delivery system, and determining where it needs to go so we can get results with the least amount of side effects
Thongnuanjan P, Soodvilai S, Fongsupa S, et al